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The U.S. Environmental Protection Agency
(U.S. EPA) recently revised its reference dose
(RfD) for methylmercury (MeHg; U.S. EPA
2001, 2003). The revision is based largely on
analyses described in a 2000 report by the
National Research Council (NRC 2000), a
body of the National Academy of Sciences.
Although the revision does not reﬂect a change
in the numerical value of the RfD (it remains
0.1 µg/kg/day), it does represent a change in
the basis. The revised RfD is now based largely
on epidemiologic data from a study of fetal
MeHg exposure resulting from maternal
intake of whale meat and ﬁsh for a cohort of
children from the Faroe Islands (NRC 2000;
U.S. EPA 2001, 2003). Benchmark dose
analyses were performed on a battery of neu-
ropsychologic tests of cognitive function
administered at 7 years of age to identify a
point of departure for RfD derivation. The
primary measure of exposure was total mercury
(Hg) levels in umbilical cord blood (i.e., µg
Hg/L blood). The RfD, however, is, by deﬁni-
tion, a dose (i.e., micrograms MeHg per kilo-
gram body weight per day)—in this case the
maternal intake dose of MeHg. To derive an
RfD from a benchmark dose based on cord
blood data, it is necessary to estimate an empir-
ical factor that relates the cord blood Hg con-
centration to a corresponding maternal blood
Hg concentration; the latter can then be used
in the one-compartment pharmacokinetic
model employed by the U.S. EPA to estimate
an associated steady-state dose. This exercise is
analogous to the need to relate hair Hg levels
to maternal blood levels, as was done in the
derivation of the prior RfD (U.S. EPA 1997).
The relationship between cord blood and
maternal blood can be expressed as the ratio
Hgc:Hgm, where c and m designate cord blood
and maternal blood, respectively. This cord
blood:maternal blood Hg concentration ratio
(henceforth, the cord:maternal ratio), as well as
the other factors in the one-compartment
pharmacokinetic model, describes a property
whose values differ among individuals in a het-
erogeneous population. For example, Vahter et
al. (2000) found individual ratios ranging from
0.4 to 4.9; Dennis and Fehr (1975) found
ratios ranging from 0.6 to 5.7; and Fujita and
Takabatake (1977) found ratios of 0.8–4.4.
The cord:maternal ratio can therefore be
described in terms of its central tendency esti-
mate and the variability about that central ten-
dency. Although there have been some efforts
to estimate a central tendency value of the
cord:maternal ratio, little effort has gone into
describing its variability. Based on a partial
review of the published literature for several
populations, the NRC report concluded that
the central tendency for cord:maternal ratio
was 1.2–1.3 at most. On the basis of a more
comprehensive review of 21 studies reporting
cord-blood and maternal-blood data, the U.S.
EPA (2001, 2003) estimated a cross-study cen-
tral estimate for the cord:maternal ratio of 1.7.
The U.S. EPA (2001, 2003) estimated a
5th–95th percentile range in the ratio of 3.5.
In revising the RfD, however, the U.S. EPA
chose not to make a numerical adjustment in
the dose conversion based on a revised estimate
of the central tendency of the ratio, implicitly
applying a ratio of 1.0. Instead, the agency
chose to consider such differences as additional
aspects of toxicokinetic variability and uncer-
tainty to be included in the determination of
the overall uncertainty factor for the estimate
of maternal dose (U.S. EPA 2001, 2003). The
NRC (2000) recommended that the overall
variability in the model relating maternal
blood Hg to the maternal MeHg dose be
accounted for by applying a factor of 2 for tox-
icokinetic variability to the central tendency
estimate of maternal dose (Clewell et al. 1999;
NRC 2000; Stern 1997; Stern et al. 2002;
Swartout and Rice 2000). The U.S. EPA
(2001, 2003) applied an overall factor of 3
for toxicokinetic variability to the central ten-
dency estimate of maternal dose, in contrast
to the NRC’s factor of 2, apparently, in part,
to account for the added variability associated
with the cord:maternal ratio.
A formal probabilistic analysis of the con-
tribution of variability in the cord:maternal
ratio to overall variability in toxicokinetics as
estimated with the one-compartment pharma-
cokinetic model has yet to be done. The ﬁrst
step to undertaking such an analysis is to gen-
erate a statistical distribution describing both
the central tendency and population variability
about the central tendency of this ratio. In this
article, we describe such a distribution derived
from a formal meta-like analysis of the pub-
lished studies. Importantly, because the rela-
tionships between the RfD and the maternal
intake dose, and between the maternal intake
dose and the fetal blood concentration, are all
assumed to be linear, a significant departure
from the assumption of central tendency value
for cord:maternal ratio of 1.0 would have an
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In the current U.S. Environmental Protection Agency reference dose (RfD) for methylmercury,
the one-compartment pharmacokinetic model is used to convert fetal cord blood mercury (Hg)
concentration to a maternal intake dose. This requires a ratio relating cord blood Hg concentra-
tion to maternal blood Hg concentration. No formal analysis of either the central tendency or
variability of this ratio has been done. This variability contributes to the overall variability in the
dose estimate. A ratio of 1.0 is implicitly used in the model, but an uncertainty factor adjustment
is applied to the central tendency estimate of dose to address variability in that estimate. Thus,
incorporation of the cord:maternal ratio and its variability into the estimate of intake dose could
result in a signiﬁcant change in the value of the RfD. We analyzed studies providing data on the
cord:maternal blood Hg ratio and conducted a Monte Carlo–based meta-analysis of 10 studies
meeting all inclusion criteria to generate a comprehensive estimate of the central tendency and
variability of the ratio. This analysis results in a recommended central tendency estimate of 1.7, a
coefﬁcient of variation of 0.56, and a 95th percentile of 3.4. By analogy to the impact of the simi-
lar hair:blood Hg ratio on the overall variability in the dose estimate, incorporation of the
cord:maternal ratio may support a 3-fold uncertainty factor adjustment to the central tendency
estimate of dose to account for pharmacokinetic variability. Whether the information generated in
this analysis is sufﬁcient to warrant a revision to the RfD will depend on the outcome of a com-
prehensive reanalysis of the entire one-compartment model. We are currently engaged in such an
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Research | Articleequally signiﬁcant effect on the estimate of a
maternal dose. It might also have a similar
effect on the RfD, depending on the outcome
of a probabilistic analysis.
Materials and Methods
Criteria for selection of studies. We conducted
a search of the peer-reviewed literature to
identify reports providing data on Hg and/or
MeHg concentration in maternal and fetal
cord blood. In conducting an assessment that
employs multiple independent sources of data,
several basic requirements must be met: The
studies should all be of a minimum acceptable
overall scientiﬁc quality; the studies should all
contain data that are relevant to the assess-
ment; the data should be sufﬁciently robust to
support statistically meaningful conclusions;
and the data should be collected and expressed
in a manner that allows comparability across
studies. To ensure that these requirements
were met, we reviewed the reports according
to the following speciﬁc a priori criteria:
a) If data are reported in terms of total
Hg, the mean concentration in the sample
population must be > 2.0 ppb to minimize
signiﬁcant contributions to the cord:maternal
ratio from background sources of inorganic
Hg unrelated to MeHg. Populations with lit-
tle or no fish consumption appear to have
characteristic blood Hg concentrations of
about 2 ppb or less (Brune et al. 1991). In the
absence of signiﬁcant ﬁsh consumption, total
Hg concentration in blood will likely reﬂect a
significant contribution from inorganic Hg
from the diet and/or from dental amalgams.
b) The total sample size must be > 10.
Although this value is somewhat arbitrary, it
can be viewed as an approximate minimum
value consistent with deriving a reasonable
estimate of the mean and standard deviation
(SD) of a population distribution.
c) The correlation (r) between maternal and
cord blood Hg (or MeHg) concentration must
be ≥ 0.4. The underlying premise of this assess-
ment is that the MeHg-derived cord and mater-
nal blood Hg concentrations both originate
from maternal MeHg, and both concentrations
are pharmacokinetically linked. This implies
that a reasonable correlation should exist
between these two parameters. The lack of such
a correlation in a study suggests either that
other (i.e., non-MeHg) sources of Hg incapable
of readily crossing the placenta significantly
contribute to the maternal blood Hg concentra-
tion or that the analytical procedure employed
in that study was insufﬁciently precise.
d) The Hg (or MeHg) concentration must
be measured in whole blood. The pharmaco-
kinetic model predicts concentration in whole
blood. Concentrations of Hg in individual
blood components cannot readily be recom-
bined in a manner that provides useful infor-
mation on the variability in concentration in
the whole blood.
e) At a minimum, studies must provide
data on the mean and SD of the concentration
of Hg or MeHg in maternal and cord blood,
and the correlation coefﬁcient relating the two
parameters.
Estimation of ratio parameters. The goal of
this analysis is to estimate not only the central
tendency of the cord:maternal ratio but also
the distribution of the ratio. It was therefore
necessary to use the reported or simulated val-
ues of individual paired cord and maternal
concentrations rather than the summary mean
cord and maternal concentrations from studies.
Given the non-normal and correlated distribu-
tion of cord and maternal blood Hg concentra-
tions, the ratio of mean cord and maternal
values will not yield a reliable estimate of the
true mean of the distribution of the ratio.
Therefore, the parameters of statistical distribu-
tions for the cord:maternal ratio were estimated
in one of three ways: a) as reported, if statistics
were provided for the ratio; b) by calculation,
when cord and maternal Hg concentration data
were reported for each mother–child pair; and
c) by simulation when only summary statistics
and the correlation coefficient were reported
for the cord and maternal blood Hg levels.
Only one study reported the mean and SD of
the cord:maternal ratio (Soria et al. 1992). For
three studies (Dennis and Fehr 1975; Fujita
and Takabatake 1977; Vahter et al. 2000),
cord and maternal Hg concentrations were
available for each mother–child pair and could
therefore be used to calculate the ratio. The
data corresponding to Vahter et al. (2000)
were supplied by the authors. Dennis and Fehr
(1975) presented data for the northern
Saskatchewan cohort as a scatter plot (their
Figure 1). The ﬁgure was scanned as a JPEG
ﬁle using ArcMap to obtain numerical values
for each cord and maternal pair (Dennis and
Fehr 1975).
Most of the studies meeting the selection
criteria only reported the mean, SD, and corre-
lation coefﬁcient for maternal and child blood
Hg levels. In such cases, the joint distribution
of maternal and child blood Hg levels was sim-
ulated using Monte Carlo sampling. In brief,
this approach draws simulated paired samples
of cord blood and maternal blood Hg from
prespecified statistical distributions of each
parameter. The statistical distributions were
initially assumed to be log-normal in shape
based on examination of those data sets where
raw data were available. The mean and SD of
each distribution were speciﬁed by the respec-
tive reports, as was the correlation coefﬁcient.
The samples of cord and maternal blood Hg
concentration were randomly drawn from their
respective distribution, except that the relation-
ship between the cord and maternal values in
each pair was constrained by the reported cor-
relation coefﬁcient. A ratio value was calculated
for each sampled maternal–cord data pair, and
the overall estimate from each study was calcu-
lated from the simulated ratio values across all
samples. Monte Carlo simulation was carried
out using @RISK, version 3.5.2 (Palisade
Corp., Newfield, NY). Because the distribu-
tional parameters reported for the sample pop-
ulations were assumed to provide a reasonable
estimate of the underlying population, the
number of simulation samples of each distribu-
tion was not constrained by the original sample
size but was selected so as to give a reasonable
simulation of the maternal, cord, and ratio dis-
tributions.
For the analysis of the individual studies,
the distributions were sampled with 5,000
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Table 1. Studies included.
Mercury Cord blood Maternal blood
Sample species parameters parameters Cord–maternal
Study Population size analyzed (mean ± 1 SD) (mean ± 1 SD) correlation
Lauwreys et al. 1978 Belgium 468 Total Hg 1.42 ± 0.85 mg/100 mL 1.26 ± 0.69 mg/100 mL 0.62
Vahter et al. 2000 Solna, Sweden 79a MeHg 1.75 ± 1.05 mg/L 0.97 ± 0.54 mg/L 0.77
Tsuchiya et al. 1984 Nagoya City, Japan 221 MeHg 14 ± 9 mg/L 9 ± 5 mg/L 0.59
Bjerregaard and Hansen 2000 Greenland Inuit 178 Total Hg 35.6 ± 32.1 mg/L 16.8 ± 13.6 mg/L 0.84
Hansen et al. 1990 Greenland Inuit 37 MeHg 80.2 ± 52.2 mg/L 38.1 ± 22 mg/L 0.8
Nishima et al. 1977 Tokyo, Japan 48 MeHg 13 ± 6 ng/g 6 ± 3 ng/g 0.74
Ong et al. 1993 Singapore 29 MeHg 8.82 ± 5.39 mg/L 5.46 ± 4.59 mg/L 0.44
Soong et al. 1991 Taiwan 85 Total Hg 28.8 ± 26.46b mg/L 19.4 ± 13.83b mg/L 0.75
Soria et al. 1992 Seville, Spain 18c Total Hg 5.25 ± 2.83 mg/L 4.97 ± 1.87 mg/L 0.53
Dennis and Fehr 1975 Northern Saskatchewan 41d Total Hg 26.66 ± 23.41 mg/L 15.33 ± 14.24 mg/L 0.88
aMatched samples for maternal blood at 36 weeks. bSD calculated from reported SE. cCord venous blood. dForty-three mother–child pairs are documented, but only 41 observations
were generated from the scanned ﬁgure.iterations because we found this to give a
reproducible estimate of the ratio parameters.
Empirical distributions and distributions gen-
erated by sampling were assessed for log-nor-
mality using BestFit, version 2.0d (Palisade
Corp.). Additional statistical analysis was car-
ried out using Statistica, release 5.5A (Statsoft
Inc., Tulsa, OK). For the comparison of ratio
values from studies measuring MeHg only,
and studies measuring total Hg only, the
number of sampling iterations of studies for
which raw data were not available was equal
to the number of paired observations reported
for that study
Validation studies. We investigated the
validity of the assumptions and methods
employed in the simulation of the cord:mater-
nal ratio and its statistical parameters using
four studies that provided direct information
on the cord:maternal ratio. Three of these
studies (Dennis and Fehr 1975; Soria et al.
1992; Vahter et al. 2000) met the selection cri-
teria. A fourth study not meeting the selection
criteria, by Fujita and Takabatake (1977), was
nonetheless used to assess the simulation
approach. We compared the reported or calcu-
lated values of the ratios from these four stud-
ies with the values estimated using the Monte
Carlo simulation approach. This comparison
addressed both the assumption of the log-nor-
mal shape of the distributions and the simula-
tion methodology. In addition, we investigated
the assumption of log-normality in the study
by Vahter et al. (2000) directly by comparing
the empirical distribution of the cord and
maternal blood Hg concentrations to the best-
ﬁtting log-normal distribution based on maxi-
mum likelihood estimation.
Meta-analysis. To employ information
about the cord:maternal blood Hg ratio in a
risk-based probabilistic assessment of the
MeHg RfD, it is necessary to derive a sum-
mary expression of the population distribu-
tion of the ratio. Our primary approach for
combining the data from all included studies
to provide such a summary expression was
based on the assumption that there is an
underlying distribution of ratio values com-
mon to all populations, and that each study
yields a sample of that common distribution.
Under this assumption, the reliability of an
estimate from any given study is largely a
function of the sample size (n) of that study.
Each study is therefore sampled in proportion
to its sample size (n-weighted). As an alterna-
tive approach, we also considered the possibil-
ity that different populations do not
necessarily have the same underlying distribu-
tion for the cord:maternal blood Hg ratio,
and that each study therefore yields a ratio
distribution speciﬁc to the population under
study. Under this assumption, each study is
an independent observation, and all studies
are therefore given equal weight. Also inher-
ent in this approach is the notion that the
available data represent a random sample
from among the various populations con-
tributing to the heterogeneous target popula-
tion for the RfD. For meta-analysis using this
approach, the total number of sampling itera-
tions was equal to 5,000 times the number of
pooled studies in each analysis. Meta-analyses
for the total Hg-only and MeHg-only studies
were conducted to examine the possibility
that the type of Hg included in the measure-
ments (i.e., MeHg only vs. total Hg) influ-
enced the resulting ratio. Meta-analyses for
these subsets of studies were carried out in the
same manner as the analyses of the total set of
pooled samples.
Results
Our search of the scientiﬁc literature yielded 22
studies providing data on maternal and cord
blood Hg concentrations. Ten studies met all
criteria for evaluation of the cord:maternal Hg
ratio (Table 1). These studies address at least
eight geographically distinct populations and
several different ethnic groups. Reasons for
exclusion of the remaining studies are pre-
sented in Table 2. The most common reasons
for excluding studies were samples < 10 and
correlations between cord blood or maternal
blood < 0.4.
The data from Vahter et al.’s (2000) study
were chosen to examine the assumption of log-
normality because the study provides the
largest data set among studies providing direct
information on individual cord and maternal
concentrations. The raw data ( Vahter M.
Personal communication) for both maternal
and cord blood Hg concentrations were ﬁtted
to their maximum-likelihood log-normal dis-
tributions using curve-fitting software. The
results assessed using the Kolmogorov-Smirnov
goodness-of-fit test (Hgm – D = 0.066,
p > 0.15; Hgc – D = 0.071, p > 0.15; where D
is equal to the maximum vertical difference
between the empirical and theoretical distribu-
tions) indicate a close fit and are consistent
with the assumption of log-normality that we
applied to both cord and maternal blood Hg
concentrations in the Monte Carlo simulation
procedure. We obtained similar results from
the other studies providing individual concen-
tration data (Dennis and Fehr 1975; Fujita
and Takabatake 1977; Soria et al. 1992).
Table 3 presents the cord:maternal blood
Hg ratios calculated or estimated from each of
the included studies. Also presented are the
SDs and coefﬁcients of variation (CV) of each
ratio. The CV (also referred to as the relative
SD) is defined as SD/mean and provides a
basis for comparing the extent of the variabil-
ity in the ratio across different studies. These
results are presented graphically in Figure 1.
The ratios for each of the included studies
were > 1.0. The mean ratio was 1.9, the small-
est value was 1.1, and five of the 10 studies
had ratios > 2.0. With one exception, the CVs
of the ratios fell in a relatively narrow range of
0.34–0.56. Based on examination of scatter
plots of the ratios from each of the studies to
either the maternal or cord blood Hg concen-
trations for the same studies, there was no
obvious correlation across studies between the
cord:maternal ratio and either of the blood
concentrations.
Table 4 presents a comparison of the
cord:maternal ratio values estimated using the
Monte Carlo simulation approach to the
reported or calculated ratio values for the four
studies providing this information. Note that
the study of Fujita and Takabatake (1977) was
not among those included because of the small
Article | Cord blood:maternal blood methylmercury ratio
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Table 2. Studies excluded.
Study Reasons for exclusion
Ramirez et al. 2000 Small sample: n = 5 for paired samples
No correlation reported
Sandborgh-Englund et al. 2001 Small sample. Data as reported in ﬁgure and table disagree: 
n = 7 (ﬁgure), n = 4 (table)
Suzuki et al. 1984 Small sample: n = 7
Baglan et al. 1974 Hg concentration reported on a dry-weight basis
Fujita and Takabatake 1977 r = 0.13 (with outliers); r = –0.65 without outliers. Correlation is 
unstable
Pitkin et al. 1976 r = 0.31. Only 36% of samples had detectable Hg in both cord and 
maternal blood
Ratio values not recoverable due to inclusion of nondetects values as
0 in summary data
Yang et al. 1997 Small sample: n = 9
Kuhnert et al. 1981 Hg concentration reported separately for erythrocytes and plasma; 
individual hematocrit data not reported
Kuntz et al. 1982 r = 0.19
Cord and maternal Hg concentration < 2.0 ppb
Sikorski et al. 1989 r = 0.36
Data reported as geometric means and conﬁdence intervals; data 
cannot be consistently converted to arithmetic parameters
Truska et al. 1989 Hg concentration reported separately for erythrocytes and plasma; 
individual hematocrit data not reported
Muckle et al. 2001 Inconsistent statistical reportingcord–maternal correlation coefficient. For
three of the studies, the agreement between
the observed and predicted ratio parameters
was quite close. For Dennis and Fehr’s (1975)
study, the estimate of the mean ratio was also
in close agreement, whereas the estimated SD
was 35% smaller than the value calculated
directly from the data. The reason for this dis-
crepancy is not clear to us. These comparisons
suggest that the simulation approach can pro-
vide a reasonable estimate of the ratio and its
associated parameters for those studies provid-
ing only summary statistical data for cord and
maternal Hg concentrations.
We compared the ratios generated from
studies in which MeHg was measured (n = 5,
mean = 1.94) with the ratios generated from
studies in which total Hg was measured (n = 5,
mean = 1.53). The difference was signiﬁcantly
different (p < 0.0001) based on t-test as well as
analysis of variance controlling for independent
interstudy differences. Meta-analyses were
therefore conducted for all studies combined as
well as for MeHg and total Hg studies sepa-
rately. Table 5 presents the statistical parame-
ters of the ratio distributions generated by the
two meta-analysis approaches described in
“Materials and Methods.” In general, the
unweighted analyses yield a larger mean ratio
than do the n-weighted analyses, and the
MeHg studies yield a larger mean ratio than do
the total Hg studies. To help apply the results
of these analyses in the derivation of the MeHg
RfD, it would be useful to summarize the dis-
tributions in terms of simple parametric distri-
butions. We previously investigated the ﬁt of
Vahter et al.’s (2000) maternal and cord Hg
distributions using a goodness-of-fit test.
However, given the large number of simula-
tion samples resulting from the meta-analyses,
goodness-of-ﬁt tests will have large power to
identify as statistically significant even small
divergences from the ideal maximum likeli-
hood ﬁt. Thus they are of limited use for deter-
mining the practical utility of the best-fit
parametric distributions. We therefore investi-
gated the log-normal ﬁt of the meta-analyses
data using a graphical approach. Figures 2 and
3 present the normal probability plots of the
log-transformed meta-analysis simulation data
for all studies combined. For the data between
the 0.5th and 95.5th percentiles of the distrib-
ution, the maximum-likelihood log-normal
distributions provide a close fit to the simu-
lated data. Thus, for the primary (n-weighted)
meta-analysis, the maximum-likelihood esti-
mate gives a log-normal distribution with a
mean of 1.7 and an SD of 0.9, and for the
alternative (unweighted) analysis, the ratio can
be described as a log-normal distribution with
a mean of 1.9 and an SD of 1.1.
Discussion
This analysis among widely differing pop-
ulations indicates that the ratio of MeHg or
MeHg-derived Hg in fetal cord blood to
maternal blood, at least at the time of deliv-
ery, is greater than the value of 1.0 originally
assumed in the NRC (2000) and U.S. EPA
(2001, 2003) assessments. Doi et al. (1984)
discussed possible reasons for the increased
concentration of MeHg in cord blood relative
to maternal blood. They suggested that the
binding of MeHg to hemoglobin is the key
factor in determining the relative MeHg con-
centration in the blood, with the greater con-
centration in the cord blood resulting from
the larger hematocrit and greater hemoglobin
concentration in the newborn. They found
no evidence for a signiﬁcantly greater MeHg
binding capacity in fetal hemoglobin than in
adult hemoglobin. In addition to maternal
hematocrit decreasing during pregnancy,
maternal plasma albumin concentration also
decreases during pregnancy. This would
appear to favor increasing concentrations of
unbound xenobiotics. At the same time, the
concentration of albumin in fetal plasma
increases, providing increased opportunity for
binding and retention of xenobiotics, presum-
ably including MeHg (Manson 1986). Fetal-
specific serum albumin proteins, such as
α-fetoprotein (Deutsch 1991), may also lead
to greater inherent affinity of fetal blood for
MeHg compared with maternal blood. To
date, however, the differential binding of
MeHg to fetal and adult serum proteins does
not appear to have been investigated. Finally,
although MeHg passes freely across the pla-
centa from mother to fetus because of the
binding of the cysteine–MeHg complex by
the neutral amino acid carrier (Kajiwara et al.
1996, 1997; Mokrzan et al. 1995), absence or
reduced afﬁnity of an analogous carrier on the
fetal side of the placenta could also result in
MeHg accumulation in fetal blood.
Two of the available studies contained all
necessary information for assessing the
cord:maternal Hg ratio but were excluded
from the analysis because they narrowly failed
to meet the a priori sample size requirement
of 10. The mean cord:mean maternal MeHg
ratio in Yang et al.’s (1997) study (non-occu-
pationally exposed group, n = 9) was 1.67, and
that in Suzuki et al.’s (1984) study (n = 7) was
1.73. These values are quite close to the means
generated in the meta-analyses. Therefore,
omission of these studies from the formal
analysis had little effect on the results of the
analysis. Two of the excluded studies that
reported correlation coefﬁcients only slightly
smaller than the a priori requirement of 0.4
also had methodologic and/or reporting prob-
lems that created significant difficulties with
their inclusion in the formal analysis. In Pitkin
et al.’s (1976) study (r = 0.31, summary mean
cord:maternal ratio = 1.2), only 36% of the
samples had detectable levels of Hg in both
cord and maternal blood. The statistical para-
meters for the study population were reported
by the authors assuming that Hg concentration
below the detection limit was 0 µg/L, thus pre-
cluding accurate reconstruction of the ratio
and its parameters. In the Sikorski et al. (1989)
study (r = 0.36, summary mean ratio = 1.0),
means, SDs, and confidence intervals were
reported on the logarithmic scale. Conversion
to the arithmetic scale was uncertain because of
the reporting of asymmetrical log conﬁdence
intervals. The two studies with low correlation
coefficients [Fujita and Takabatake (1977),
r = 0.13; Kuntz et al. (1982), r = 0.19] failed to
meet other inclusion criteria or had signiﬁcant
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Table 3. Cord:maternal Hg ratios for studies meeting the inclusion criteria (calculated values are the average
of ﬁve simulations of 5,000 iterations each).
Hgc:Hgm
Study (meeting selection criteria) (cord blood:maternal blood Hg ratio) SD CV
Lauwreys et al. 1978a 1.23 0.60 0.49
Vahter et al. 2000b 1.89 0.71 0.38
Tsuchiya et al. 1984 1.70 0.92 0.54
Bjerregaard and Hansen 2000 2.21 0.98 0.44
Hansen et al. 1990 2.18 0.81 0.37
Nishima et al. 1977 2.32 0.79 0.34
Ong et al. 1993 2.30 1.85 0.80
Soong et al. 1991 1.54 0.86 0.56
Soria et al. 1992b 1.09 0.50 0.46
Dennis and Fehr 1975b 2.09 1.17 0.56
Mean 1.86 — 0.49
aBased on values as reported in units of µg/100 mL. bRatio calculated on the basis of reported raw data, not on sampled
distributions.
Figure 1. Percentiles of cord:maternal Hg ratios for
studies meeting the inclusion criteria. Box plot:
box, 25th–75th percentiles; center line, median
value; whiskers, 5th/95th percentiles. Names on
x-axis refer to references cited in Table 1.
H
g
c
/
H
g
m
6
5
4
3
2
1
0 Lauwreys
Vahter
Tsuchiya
Burregaard
Hansen
Nishima
Ong
Soong
Soria
Dennismethodologic problems (Table 2). Thus, no
study was excluded solely on the basis of its
correlation coefﬁcient.
Three of the four studies that were avail-
able for evaluating the accuracy of the Monte
Carlo simulation approach indicated that this
approach resulted in a close agreement with
both the reported mean and SD. For the
fourth study, the estimate of the SD was
biased low despite a good fit of both the
maternal and cord blood Hg concentrations to
log-normal distributions. Although the rea-
sons for this are not clear to us, if there is
indeed a bias in the simulation approach lead-
ing to an underestimation of the SD, the esti-
mates of the upper percentiles of the ratio
(e.g., 90th, 95th percentiles) will likewise be
underestimated.
The mean cord:maternal ratio estimated
from the pooled MeHg-only studies was sig-
nificantly larger than the mean ratio calcu-
lated from the pooled total Hg-only studies.
Because total Hg and MeHg concentration
measurements differ by the concentration of
inorganic Hg, this suggests the possibility that
the type of Hg measurement could inﬂuence
the parameters of the ratio. There are three
possible sources of inorganic Hg in blood:
nonspeciﬁc sources of ionic Hg (Hg2+) in the
diet, release of elemental Hg vapor (Hg0) from
dental amalgams, and metabolism of MeHg to
ionic Hg. Ideally, we would want to consider
only the inorganic Hg arising from metabolism
of MeHg. Ionic Hg does not readily cross the
placenta (Khayat and Dencker 1982), and the
fetus appears to have little capacity to metabo-
lize MeHg to ionic Hg (Dock et al. 1994;
Nordenhill et al. 1995). Dietary inorganic Hg
is not likely to contribute significantly to
maternal blood inorganic Hg except in popula-
tions with frequent consumption of marine
mammals that have relatively high concentra-
tions of inorganic Hg from metabolism of
MeHg. The Agency for Toxic Substances and
Disease Registry (ATSDR 1999) estimated
that dietary inorganic Hg accounts for about
2% of the Hg retained in the body in the gen-
eral population. Therefore, for most popula-
tions, essentially all of the inorganic Hg that
should be included in the ratio will be found
on the maternal side. This conclusion is consis-
tent with our observation that the cord:mater-
nal ratio calculated from MeHg-only studies is
larger than the ratio calculated from total Hg-
only studies, and suggests that the MeHg-only
ratio may overestimate the true ratio. However,
Hg0 from amalgams readily crosses the placenta
(Pamphlett and Kum-Jew 2001; Takahashi et
al. 2001; Warfvinge 2000) and can therefore
result in an overestimate of the MeHg-derived
Hg concentration in both cord and maternal
blood when total Hg studies are considered.
Because the extent of dental amalgam use
is likely to differ among individuals, popula-
tions, and ethnic groups, the effect of dental
amalgam Hg on the cord:maternal ratio esti-
mated from total Hg studies is uncertain. It is
not clear, however, that the observed difference
in the cord:maternal ratio between MeHg-only
and total Hg-only studies in fact derives from
the inﬂuence of inorganic Hg. Both Hansen et
al. (1990) and Bjerregaard and Hansen (2000)
studied Inuit in western Greenland. The for-
mer study measured MeHg, and the latter total
Hg. The ratios from both studies were nearly
identical (Table 3). Dennis and Fehr (1975)
measured total Hg in two populations, one in
northern Saskatchewan, and one in southern
Saskatchewan (the data for only the northern
group were available for our analysis). The
summary mean ratio in the former was 1.8 and
1.1 in the latter. The northern group ate more
ﬁsh and had blood concentrations two to four
times higher than the southern group, but the
two groups presumably did not have signifi-
cantly different inorganic Hg exposures. In
light of this uncertainty, we have presented the
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Table 4. Comparison of reported and calculated ratios for studies reporting ratio data.
Reported Reported SD Calculated mean Calculated SD
Study mean Hgc:Hgm Hgc:Hgm Hgc:Hgm Hgc:Hgm
Vahter et al. 2000 1.91 0.76 1.89 0.71
Soria et al. 1992 1.11 0.51 1.09 0.50
Fujita and Takabatake 1977a 1.4 0.9 1.47 1.11
Dennis and Fehr 1975 2.09 1.17 1.92 0.76
aDid not meet selection criteria due to weak maternal–cord Hg correlation.
Table 5. Ratios derived from meta-analyses (calculated values are the average of ﬁve simulations).
All studies combined MeHg studies only Total Hg studies only
n-Weighted Unweighted n-Weighted Unweighted n-Weighted Unweighted
meta-analysis meta-analysis meta-analysis meta-analysis meta-analysis meta-analysis
Mean 1.65 1.85 1.89 2.08 1.51 1.60
SD 0.93 1.07 0.98 1.11 0.85 0.87
CV 0.56 0.58 0.52 0.53 0.56 0.54
25th percentile 1.00 1.13 1.23 1.38 0.92 0.98
50th percentile 1.45 1.65 1.71 1.88 1.32 1.41
75th percentile 2.07 2.32 2.34 2.52 1.90 2.01
90th percentile 2.81 3.10 3.07 3.30 2.61 2.72
95th percentile 3.37 3.71 3.63 3.93 3.14 3.24
Figure 2. Normal probability plot of log-transformed n-weighted meta-analysis
simulation data. This ﬁgure displays the ﬁt of the meta-analysis simulation data
(after logarithmic transformation) to the theoretical normal distribution (the
blue line). Deviations of the data points from the blue line indicate deviations
from true log-normality.
Figure 3. Normal probability plot of log-transformed unweighted meta-analysis
simulation data. This ﬁgure displays the ﬁt of the meta-analysis simulation data
(after logarithmic transformation) to the theoretical normal distribution (the
blue line). Deviations of the data points from the blue line indicate deviations
from true log-normality.
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–1.0 –0.6 –0.2 0.2 0.6 1.0 1.4ratios and their distributions calculated based
on all included studies as well as on MeHg-
only and total Hg-only studies. The differences
among these values are relatively small, and the
potential inﬂuence of inorganic Hg is modest.
In light of the various uncertainties, we recom-
mend that the ratio values from the analysis of
all studies (Table 5, n-weighted) be used for
purposes of risk assessment.
Recall that prior estimates of overall vari-
ability in the one-compartment pharmaco-
kinetic model by the NRC (2000) and Stern et
al. (2002) concluded that applying an uncer-
tainty factor of 2 to the central tendency esti-
mate of dose could essentially account for the
variability in dose corresponding to a given
maternal blood concentration. That conclu-
sion, however, was speciﬁc to maternal blood
and did not consider the variability around the
central tendency estimate of the cord:maternal
blood Hg ratio. These same sources concluded
that applying an uncertainty factor of 3 to the
central tendency estimate of dose could account
for the overall variability in the dose corre-
sponding to a given maternal hair concentra-
tion. The additional overall variability in the
latter case results from the additional pharma-
cokinetic variability inherent in the empirical
ratio relating maternal hair Hg concentration
to maternal blood Hg concentration. From the
standpoint of overall variability in the one-
compartment model, that ratio is analogous to
the cord blood:maternal blood ratio derived in
the present analysis. Interestingly, the CV
describing the variability in the hair:blood
ratio is similar to that derived here for the
cord:maternal ratio. We have not yet com-
pleted a comprehensive reanalysis of dose esti-
mation using the one-compartment model
(including the cord:maternal ratio) in the con-
text of the MeHg RfD derivation. However,
by comparison with the variability in the
model with the hair:blood ratio included,
incorporation of the cord:maternal ratio in the
model appears to support the use of a full
3-fold uncertainty factor for toxicokinetic vari-
ability alone. Whether, ultimately, a revision
will be needed to the RfD for neurologic devel-
opmental effects as a result of the present
analysis will depend on the results of a formal
comprehensive reanalysis. We are currently
engaged in such an analysis.
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